We are very pleased to announce that Neurosoft Bioelectronics has been selected to participate in the Medlim Fast Track Acceleration Program. This year the program has selected 9 promising startups developing breakthrough technology in the Cardiovascular, Diabetes, Neurological & Orthopedic fields. Each startup will receive support in bringing their medical devices to the market through workshops, interaction with experts, coaching sessions and a final pitch event with investors.
The Medlim program was initiated by Medtronic and LIOF, together with the Brightlands Maastricht University, Medace, and imec.istart centers. These world-class partners provide expertise in the domains of business, medical device development, regulatory, IP and financing.
Learn more about the program on the Medlim website.